Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Nov;53(11):4915-20.
doi: 10.1128/AAC.00078-09. Epub 2009 Sep 8.

In vitro activity of nemonoxacin, a novel nonfluorinated quinolone, against 2,440 clinical isolates

Heather J Adam  1 , Nancy M Laing, C Richard King, Ben Lulashnyk, Daryl J Hoban, George G Zhanel
Affiliations

In vitro activity of nemonoxacin, a novel nonfluorinated quinolone, against 2,440 clinical isolates

Heather J Adam et al. Antimicrob Agents Chemother. 2009 Nov.

Abstract

The in vitro activity of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, was tested against 2,440 clinical isolates. Nemonoxacin was at least fourfold more active than levofloxacin and moxifloxacin against most gram-positive cocci tested (shown by the following MIC(90)/range [microg/ml] values; community-associated methicillin [meticillin]-resistant Staphylococcus aureus, 0.5/0.015 to 2; Staphylococcus epidermidis, 0.5/0.015 to 4 for methicillin-susceptible staphylococci and 2/0.12 to 2 for methicillin-resistant staphylococci; Streptococcus pneumoniae, 0.015/< or = 0.008 to 0.25; Enterococcus faecalis, 1/0.03 to 128). Nemonoxacin activity against gram-negative bacilli was similar to levofloxacin and moxifloxacin (MIC(90)/range [microg/ml]; Escherichia coli, 32/< or = 0.015 to > or = 512; Klebsiella pneumoniae, 2/< or = 0.015 to 128; K. oxytoca, 0.5/0.06 to 1; Proteus mirabilis, 16/0.25 to > or = 512; Pseudomonas aeruginosa, 32/< or = 0.015 to > or = 512; Acinetobacter baumannii, 1/0.12 to 16).

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Nemonoxacin chemical structure. Me, methyl group.
See this image and copyright information in PMC

References

    1. Andersson, M. I., and A. P. MacGowan. 2003. Development of the quinolones. J. Antimicrob. Chemother. 51(Suppl. 1):1-11. - PubMed
    1. Barry, A. L., P. C. Fuchs, and S. D. Brown. 2001. In vitro activities of three nonfluorinated quinolones against representative bacterial isolates. Antimicrob. Agents Chemother. 45:1923-1927. - PMC - PubMed
    1. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
    1. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement. M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA.
    1. Golding, G., J. Campbell, D. Spreitzer, J. Veyhl, K. Surynicz, and A. Simor. 2008. A preliminary guideline for the assignment of methicillin-resistant Staphylococcus aureus to a Canadian pulsed-field gel electrophoresis epidemic type using spa typing. Can. J. Infect. Dis. Med. Microbiol. 19:273-281. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources